Kenji Tago

Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Topics

Top Venues

The FEBS journal

Molecular oncology

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Shingo Hokimoto, Megumi Funakoshi-Tago, Kenji Tago
Identification of DDX5 as an indispensable activator of the glucocorticoid receptor in adipocyte differentiation. The FEBS journal (2022)
Fumiya Anzai, Tadayoshi Karasawa, Takanori Komada, Naoya Yamada, Yutaka Miura, Ariunaa Sampilvanjil, Chintogtokh Baatarjav, Kenta Fujimura, Takayoshi Matsumura, Kenji Tago, Hiroshi Kurosu, Yasuchika Takeishi, Makoto Kuro-O, Masafumi Takahashi
Calciprotein Particles Induce IL-1β/α-Mediated Inflammation through NLRP3 Inflammasome-Dependent and -Independent Mechanisms. ImmunoHorizons 5 (7) (2021)
Satoshi Ohta, Kenji Tago, Takahiro Kuchimaru, Megumi Funakoshi-Tago, Hisanaga Horie, Chihiro Aoki-Ohmura, Jitsuhiro Matsugi, Ken Yanagisawa
The role of MerTK in promoting cell migration is enhanced by the oncogenic Ras/IL-33 signaling axis. The FEBS journal (2021)
Yuki Uchihara, Kenji Tago, Hiroomi Tamura, Megumi Funakoshi-Tago
EBP2, a novel NPM-ALK-interacting protein in the nucleolus, contributes to the proliferation of ALCL cells by regulating tumor suppressor p53. Molecular oncology 15 (1) (2020)
Kenji Tago, Megumi Funakoshi-Tago, Satoshi Ohta, Hirotoshi Kawata, Hiroshi Saitoh, Hisanaga Horie, Chihiro Aoki-Ohmura, Junji Yamauchi, Akira Tanaka, Jitsuhiro Matsugi, Ken Yanagisawa
Oncogenic Ras mutant causes the hyperactivation of NF-κB via acceleration of its transcriptional activation. Molecular oncology 13 (11) (2019)
Yuki Miyamoto, Tomohiro Torii, Kenji Tago, Akito Tanoue, Shou Takashima, Junji Yamauchi
BIG1/Arfgef1 and Arf1 regulate the initiation of myelination by Schwann cells in mice. Science advances 4 (4) (2018)